Uniqure NV
NASDAQ:QURE
Uniqure NV
Revenue
Uniqure NV
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Uniqure NV
NASDAQ:QURE
|
Revenue
$15.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Pharming Group NV
AEX:PHARM
|
Revenue
$245.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
43%
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Revenue
€9.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
argenx SE
XBRU:ARGX
|
Revenue
$1.2B
|
CAGR 3-Years
210%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
Merus NV
NASDAQ:MRUS
|
Revenue
$43.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Revenue
€97.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Uniqure NV's Revenue?
Revenue
15.8m
USD
Based on the financial report for Dec 31, 2023, Uniqure NV's Revenue amounts to 15.8m USD.
What is Uniqure NV's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was -85%. The average annual Revenue growth rates for Uniqure NV have been -25% over the past three years , 7% over the past five years , and 14% over the past ten years .